List of bibliographic references indexed by Randomized Controlled Trials as Topic
Number of relevant bibliographic references: 8.
Ident. | Authors (with country if any) | Title |
---|
000114 (2020) |
C. Takeda [France] ; S. Guyonnet ; P J Ousset ; M. Soto ; B. Vellas | Toulouse Alzheimer's Clinical Research Center Recovery after the COVID-19 Crisis: Telemedicine an Innovative Solution for Clinical Research during the Coronavirus Pandemic. |
000197 (2020) |
Rosario Garcia-Vicu A [Espagne] ; Francisco Abad-Santos [Espagne] ; Isidoro González-Alvaro [Espagne] ; Francisco Ramos-Lima [Espagne] ; Jesús Sanz Sanz [Espagne] | Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. |
000324 (2020) |
Lisa A. Grohskopf ; Elif Alyanak ; Karen R. Broder ; Lenee H. Blanton ; Alicia M. Fry ; Daniel B. Jernigan ; Robert L. Atmar | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. |
000345 (2020) |
Lamis Kaddam [Soudan, Arabie saoudite] ; Rasha Babiker [Soudan] ; Sara Ali [Soudan] ; Shahinaz Satti [Soudan] ; Nour Ali [Soudan] ; Maha Elamin [Soudan] ; Mowaia Mukhtar [Soudan] ; Mustafa Elnimeiri [Soudan] ; Amal Saeed [Soudan] | Potential Role of Acacia Senegal (Gum Arabic) as Immunomodulatory Agent among newly diagnosed COVID 19 Patients: A structured summary of a protocol for a randomised, controlled, clinical trial. |
000404 (2020) |
Abdulrahman E. Koshak [Arabie saoudite] ; Emad A. Koshak [Arabie saoudite] ; Abdullah F. Mobeireek [Arabie saoudite] ; Mazen A. Badawi [Arabie saoudite] ; Siraj O. Wali [Arabie saoudite] ; Husam M. Malibary [Arabie saoudite] ; Ali F. Atwah [Arabie saoudite] ; Meshari M. Alhamdan [Arabie saoudite] ; Reem A. Almalki [Arabie saoudite] ; Tariq A. Madani [Arabie saoudite] | Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial. |
000737 (2020) |
Israel Júnior Borges Do Nascimento [Brésil, États-Unis] ; Thilo Caspar Von Groote [Allemagne] ; D Nal P. O'Mathúna [États-Unis, Irlande (pays)] ; Hebatullah Mohamed Abdulazeem [Allemagne] ; Catherine Henderson [Royaume-Uni] ; Umesh Jayarajah [Sri Lanka] ; Ishanka Weerasekara [Sri Lanka, Australie] ; Tina Poklepovic Pericic [Croatie] ; Henning Edgar Gerald Klapproth [Allemagne] ; Livia Puljak [Croatie] ; Nensi Cacic [Croatie] ; Irena Zakarija-Grkovic [Croatie] ; Silvana Mangeon Meirelles Guimarães [Brésil] ; Alvaro Nagib Atallah [Brésil] ; Nicola Luigi Bragazzi [Canada] ; Milena Soriano Marcolino [Brésil] ; Ana Marusic [Croatie] ; Ana Jeroncic [Croatie] | Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses. |
000792 (2020) |
Min Zhou [République populaire de Chine] ; Qijun Liang ; Qiulan Pei ; Fan Xu ; Hang Wen | Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis. |
000992 (2020) |
Maike Janssen [Allemagne] ; Ulrike Sch Kel [Allemagne] ; Carine Djuka Fokou [Allemagne] ; Johannes Krisam [Allemagne] ; Jacek Stermann [Allemagne] ; Katharina Kriegsmann [Allemagne] ; Isabella Haberbosch [Allemagne] ; Jan Philipp Novotny [Allemagne] ; Stefan Weber [Allemagne] ; Maria Vehreschild [Allemagne] ; Martin Bornh User [Allemagne] ; Lars Bullinger [Allemagne] ; Michael Schmitt [Allemagne] ; Tobias Liebregts [Allemagne] ; Peter Dreger [Allemagne] ; Hanns-Martin Lorenz [Allemagne] ; Anna Plaszczyca [Allemagne] ; Ralf Bartenschlager [Allemagne] ; Barbara Müller [Allemagne] ; Hans-Georg Kr Usslich [Allemagne] ; Niels Halama [Allemagne] ; Dirk J Ger [Allemagne] ; Richard F. Schlenk [Allemagne] ; Albrecht Leo [Allemagne] ; Stefan Meuer [Allemagne] ; Markus A. Weigand [Allemagne] ; Johann Motsch [Allemagne] ; Uta Merle [Allemagne] ; Claudia M. Denkinger [Allemagne] ; Carsten Müller-Tidow [Allemagne] | A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Randomized Controlled Trials as Topic"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i \
-Sk "Randomized Controlled Trials as Topic" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Mesh.i
|clé= Randomized Controlled Trials as Topic
}}
| This area was generated with Dilib version V0.6.37. Data generation: Thu Oct 15 09:49:45 2020. Site generation: Wed Jan 27 17:10:23 2021 | |